Search

everythinglearnresearchcommunity

for

Search:↓

Activin increases skin tumor formation, skin Tregs help hair growth, lymph-node removal doesn't improve melanoma survival, cells can revert to stem cells in wound healing, and skin bacteria produce peptides that may treat infections.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

A 70-year-old man with skin cancer on both sides of his forehead was treated with surgery and cryotherapy, highlighting the need for early detection and prevention.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.

ERG increases SOX9, promoting prostate cancer growth and invasion.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Smoking harms skin health, causing slower wound healing, more wrinkles, and worsening some skin conditions, but may protect against certain others.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Proper control of β-catenin activity is crucial for development and preventing diseases like cancer.

The document suggests a possible link between FAM111B gene mutations and increased cancer risk, particularly pancreatic cancer.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Dr. Connelly agrees that linear basal cell carcinomas might be more aggressive but highlights the study's lack of clear criteria to identify them.

The study found that the hair loss condition in Cesky Fousek dogs is influenced by multiple genes affecting skin and muscle structure, fat metabolism, and immunity.

Hair dyes and perms can damage hair and scalp, but using interventions can reduce harm.

Understanding hair follicles can lead to new treatments for hair loss and skin tumors.

Cell death shapes skin stem cell environments, affecting inflammation, repair, and cancer.

Hair keratin treatments can be harmful, potentially causing health issues like skin reactions and cancer.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

New skin lesions on the scrotum or vulva in patients with a history of internal cancer could indicate rare skin metastasis.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.